Allergy is a hyper-sensitivity to a specific substance which, if inhaled, ingested, touched or injected, causes characteristic symptoms.
ALL INMUNOTEK NEWS
AJRCCM publishes in its August issue the results of the efficacy of MV130 in the prevention of recurrent wheezing attacks in young children. This is a randomize... More info
The Journal of Allergy and Clinical Immunology publishes a study showing that mannan-allergoid conjugates reprogram human monocytes to facilitate their differen... More info
According to a study published in Frontiers in Immunology, MV130 (Bactek) and MV140 (Uromune) reduce respiratory and urinary tract infections, respectively, in ... More info
INNOVATING AND SHARING IDEAS Since 1992
From the outset, in 1992, our goal has been to offer innovative and competitive products of the highest quality, useful for professionals and safe and effective for the treatment of patients. To this end we have put together a highly professional and motivated team; we have outstanding facilities and a broad product porfolio.
Inmunotek products are approved by the Spanish Drug Agency and several international regulatory agencies and marketed in more than 50 countries all over the world.